Dosage Forms & Drug Delivery Systems – Page 18

Smoke Study Failure during aseptic filling: risk assessment for patient safety and recall

When a smoke study fails during an aseptic filling process, immediate signals or symptoms should be carefully monitored. These can include:Click to read the full article.

Pet Failure for multi-dose products: FDA-ready investigation report and batch disposition

The first step in addressing pet failure is recognizing the symptoms or signals that indicate a potential issue. Symptoms may emerge during routine QC testing, process monitoring, or following reports…

Filter Integrity Failure during hold-time study: FDA/MHRA investigation narrative and batch impact

Identifying the initial symptoms of filter integrity failure is crucial. Common signals that may indicate a problem include:Click to read the full article.

Media Fill Failure during routine EM trending: FDA/MHRA investigation narrative and batch impact

Identifying symptoms or signals indicative of media fill failures can significantly streamline investigation processes. Symptoms may include:Click to read the full article.

Ph Drift after packaging change: FDA-ready investigation report and batch disposition

The initial step in addressing pH drift involves recognizing symptoms or signals that indicate a potential issue:Click to read the full article.

Media Fill Failure during PAI readiness: how to classify deviation and set disposition

Before embarking on an investigation, it is crucial to recognize early signs indicating a potential media fill failure during Process Analytical Interactions (PAI). Symptoms may include:Click to read the full…

Sterility Test Failure during terminal sterilization: how to classify deviation and set disposition

The first step in addressing a sterility test failure during terminal sterilization is recognizing the symptoms or signals that indicate a deviation. Common manifestations may include:Click to read the full…

Ccit Failure at stability pull: risk assessment for sterility assurance

Recognizing the early signs of a Ccit failure during stability testing is crucial for rapid response. Below are common symptoms that may indicate an issue:Click to read the full article.

Endotoxin Oos during campaign changeover: data integrity checks for lab and shop floor

When an endotoxin OOS occurs, initial signals might emerge from either the manufacturing floor or the laboratory. Symptoms may include:Click to read the full article.

Filter Integrity Failure during campaign changeover: CAPA package with evidence and effectiveness checks

Identifying the symptoms of filter integrity failure is the first crucial step in any investigation. Common signals may include:Click to read the full article.

Fill Volume Variability at stability pull: risk assessment for sterility assurance

Identifying symptoms of fill volume variability begins on the production floor or within the laboratory environment. Observational signals may include the following:Click to read the full article.

Smoke Study Failure after maintenance intervention: FDA/MHRA investigation narrative and batch impact

Identifying symptoms early contributes to robust investigations. Smoke study failures, particularly after maintenance interventions, may manifest in several ways:Click to read the full article.